594.59

4.32% 22.39

United Therapeutics Corp (UTHR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt UTHR? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$572.20

Offen:

$589.47

24-Stunden-Volumen:

428.53K

Relative Volume:

0.87

Marktkapitalisierung:

$25.22B

Einnahmen:

$3.18B

Nettoeinkommen (Verlust:

$1.33B

KGV:

21.31

EPS:

27.9001

Netto-Cashflow:

$1.04B

1W Leistung:

+4.53%

1M Leistung:

+6.66%

6M Leistung:

+31.48%

1J Leistung:

+102.34%

1-Tages-Spanne:

$575.00

$609.35

1-Wochen-Bereich:

$565.02

$609.35

52-Wochen-Spanne:

$272.12

$609.35

United Therapeutics Corp Stock (UTHR) Company Profile

Firmenname

United Therapeutics Corp

Sektor

Healthcare (1107)

Branche

Drug Manufacturers - Specialty & Generic (84)

Telefon

(301) 608-9292

Adresse

1000 SPRING ST, SILVER SPRING, MD

Mitarbeiter

1,400

Twitter

Nächster Verdiensttermin

2026-05-06

Neueste SEC-Einreichungen

UTHR's Discussions on Twitter

Compare UTHR vs TAK, ZTS, TEVA, HLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
UTHR United Therapeutics Corp	594.30	24.28B	3.18B	1.33B	1.04B	27.90
TAK Takeda Pharmaceutical Co Adr	16.73	52.28B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	113.08	47.33B	9.47B	2.67B	2.28B	6.0218
TEVA Teva Pharmaceutical Industries Ltd Adr	36.20	41.76B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.225	40.70B	14.54B	2.22B	2.58B	0.4871

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-10	Eingeleitet	Raymond James	Outperform
2025-10-20	Eingeleitet	Wells Fargo	Underweight
2025-09-26	Eingeleitet	RBC Capital Mkts	Outperform
2025-06-02	Eingeleitet	Cantor Fitzgerald	Overweight
2025-04-25	Herabstufung	Wells Fargo	Overweight → Equal Weight
2025-04-21	Hochstufung	BofA Securities	Underperform → Neutral
2024-07-11	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-02-12	Hochstufung	Goldman	Sell → Neutral
2024-02-05	Eingeleitet	Leerink Partners	Outperform
2023-12-08	Eingeleitet	Wells Fargo	Overweight
2022-12-06	Eingeleitet	UBS	Buy
2022-12-05	Eingeleitet	Goldman	Sell
2022-10-11	Eingeleitet	Morgan Stanley	Overweight
2022-09-20	Bestätigt	BofA Securities	Underperform
2022-09-19	Fortgesetzt	Wedbush	Outperform
2022-02-11	Eingeleitet	BTIG Research	Neutral
2021-07-14	Hochstufung	Argus	Hold → Buy
2021-04-26	Fortgesetzt	Credit Suisse	Outperform
2021-02-01	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-09-14	Fortgesetzt	JP Morgan	Overweight
2020-06-25	Bestätigt	H.C. Wainwright	Neutral
2020-03-10	Hochstufung	Jefferies	Hold → Buy
2020-02-27	Hochstufung	Cowen	Market Perform → Outperform
2020-01-31	Hochstufung	JP Morgan	Neutral → Overweight
2019-12-03	Eingeleitet	BofA/Merrill	Underperform
2019-08-01	Hochstufung	Jefferies	Underperform → Hold
2019-08-01	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2019-07-01	Hochstufung	Credit Suisse	Neutral → Outperform
2019-05-17	Hochstufung	UBS	Sell → Neutral
2019-05-09	Hochstufung	Credit Suisse	Underperform → Neutral
2018-10-12	Hochstufung	Standpoint Research	Hold → Buy
2018-08-08	Herabstufung	Credit Suisse	Neutral → Underperform
2018-04-03	Hochstufung	Credit Suisse	Underperform → Neutral
2018-02-22	Bestätigt	Barclays	Underweight
2018-01-18	Fortgesetzt	Credit Suisse	Underperform
2017-12-27	Bestätigt	Wedbush	Outperform
2017-04-27	Bestätigt	Wedbush	Outperform
2017-03-30	Eingeleitet	UBS	Sell
2017-03-16	Eingeleitet	Credit Suisse	Underperform

Alle ansehen

United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten

02:15 AM

BTIG reiterates Neutral on United Therapeutics stock after Q1 miss By Investing.com - Investing.com Canada

02:15 AM

12:29 PM

Transcript: United Therapeutics Q1 2026 Earnings Conference Call - Benzinga

12:29 PM

11:49 AM

Earnings call transcript: United Therapeutics misses Q1 2026 earnings forecast - Investing.com

11:49 AM

10:45 AM

MannKind stock surges on United Therapeutics partnership deal - Investing.com

10:45 AM

10:23 AM

United Therapeutics stock hits all-time high at 608.87 USD - Investing.com

10:23 AM

09:19 AM

United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings - StockStory

09:19 AM

07:45 AM

United Therapeutics (UTHR) Misses Q1 Earnings and Revenue Estimates - Yahoo Finance

07:45 AM

07:32 AM

United Therapeutics (NASDAQ:UTHR) Shares Dip After Q1 2026 Earnings Miss - ChartMill

07:32 AM

07:04 AM

MannKind develops inhaled ralinepag formulation for United Therapeutics - Investing.com

07:04 AM

06:39 AM

MannKind develops inhaled ralinepag formulation for United Therapeutics By Investing.com - Investing.com Canada

06:39 AM

06:35 AM

MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases - The Manila Times

06:35 AM

United Therapeutics Corporation Reports First Quarter 2026 Financial Results - United Therapeutics Investor Relations

06:35 AM

06:34 AM

United Therapeutics: Q1 Earnings Snapshot - kare11.com

06:34 AM

06:30 AM

MannKind Announces Ralinepag Dry Powder Inhalation (DPI) - GlobeNewswire

06:30 AM

May 05, 2026

Martine Rothblatt, United Therapeutics CEO, sells $5.48m in shares By Investing.com - Investing.com India

May 05, 2026

Martine Rothblatt, United Therapeutics CEO, sells $5.48m in shares - Investing.com

May 05, 2026

United Therapeutics faces earnings test as IPF expansion looms - Investing.com

May 05, 2026